Evidence map›Paper›PMID 39845790›Full record

ArticleFrontiers in pharmacology2024

The efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopy.

Weifeng Shan, Shuying Gao, Mengting Ai, Haiyan Lan, Gongchen Duan, Xiaoli Dong, Qiaomin Xu, Yini Wu, Jimin Wu

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. RemimazolamPeerJ · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Weifeng ShanDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Shuying GaoDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Mengting AiDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Haiyan LanDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Gongchen DuanDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Xiaoli DongDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Qiaomin XuDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Yini WuDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.
Jimin WuDepartment of Anesthesiology, Lishui People's Hospital, Wenzhou Medical University Lishui Hospital, Lishui, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Remimazolam besylate and Ciprofol are newer sedatives used in minor surgeries. Propofol is a classic drug mainly used for short surgeries. This trial was conducted to compare the efficacy and safety of remimazolam besylate, ciprofol, and propofol during hysteroscopic surgeries. Methods: Patients undergoing hysteroscopy were randomly assigned to receive remimazolam besylate (Group R), ciprofol (Group C), or propofol (Group P). A total of 194 patients were assessed for eligibility. One patient in Group P was excluded because the operation had timed out of 60 min. Patients all in Group R、Group C and Group P received an induction dose of 0.2 mg/kg remimazolam besylate、0.4 mg/kg ciprofol、2.0 mg/kg propofol seperately over 30 s. A corresponding dosage of 1 mg/kg/h、0.6-1.2 mg/kg/h and 3.0-6.0 mg/kg/h was given by continuous intravenous infusion to maintain a BIS of 40-60 till the end of the surgery. The incidence rates of body movement, respiratory depression, and adverse effects were compared among the groups. Results: The incidence of injection pain was much higher in Group P (64.1%) than that in Group R (3.4%) and Group C (3.2%, both Conclusion: Considering jointly the safety and efficacy, ciprofol seems to be the best choice for sedation.

Indexed as

ciprofolefficacyhysteroscopypropofolremimazolamsafety

Identifiers

PMID39845790
PMCPMC11750796

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.